Aberrant expression of RBBP4 is implicated in poor prognosis and metastasis of multiple highly metastatic and invasive tumors, including colon cancer 21, neuroblastoma 22, and lung cancer 23. Here, RBBP4 is linked to malignant colon neoplasm.